Asian markets have just been hit hard after a sharp sell off in AI related shares, and this kind of shock often creates rare entry points for growth focused Indian stocks where management and analysts still flag strong potential. Short term fear can drag quality businesses down with everything else, giving long term investors a window. This article highlights three high conviction Indian growth stocks from that universe.
The three stocks covered below are a sample pulled from a deeper High Growth High Conviction screen. This screen surfaced another 40 Indian companies where management commentary and analyst outlooks both point to strong potential, yet they are not discussed in this article.
If you want to quickly identify and analyze those additional high conviction ideas alongside the stocks mentioned here, head straight into the High Growth High Conviction screener.
Rubicon Research develops specialty pharmaceutical products built around its RubiReten and RubiSRL drug delivery platforms. These platforms support the High Growth High Conviction theme by enabling differentiated formulations across several therapies. The business generates about ₹19.4b from pharmaceutical products and is valued at roughly ₹288.1b.
Rubicon Research lines up well with this screener because its proprietary drug delivery platforms are not just clever science projects. They sit behind a broad basket of higher value formulations and give the business levers for both growth and profitability that go beyond plain generics.
"Expansion of US manufacturing capacity through the New Jersey facility and preparation of the Pithampur site in India is expected to support a higher own manufacturing share and can support gross margin resilience and operating EBITDA over time."
The bigger test is how one concentrated push in its product mix shapes the balance between future pricing power and earnings durability.
That trade off is exactly what the full narrative for Rubicon Research unpacks, spelling out where capacity expansion, product mix and pricing power could be quietly accelerating or stalling the story.
Bajel Projects runs an EPC business focused on extra high voltage transmission and distribution, delivering turnkey lines and substations that plug directly into rising power grid build out. It generated about ₹27.5b from power transmission and distribution projects and has a market cap near ₹19.5b.
Bajel Projects ties closely to the High Growth High Conviction theme because its EPC work on high voltage lines links directly to India’s power transmission build cycle. Earnings forecasts are strong and recent ultra mega orders add visibility. However, relatively high P/E multiples mean there is significant sensitivity to any potential pressures within this growth story.
That sensitivity cuts both ways, so use the 2 key rewards and 1 important warning sign to see whether Bajel Projects’ order book is masking upside or embedding more fragility.
Syrma SGS Technology blends electronics design, engineering, and contract manufacturing, with its EMS work on PCBAs, enclosures, cable harnesses, and testing closely tied to the High Growth High Conviction theme. The stock carries a market value of about ₹291.8b.
Syrma SGS Technology brings the screener theme to life through its EMS and design work for fast growing electronics and medtech customers. A shift toward higher value projects could matter far more than simple volume gains.
"The multilayer PCB investment of about ₹800 crores, supported by a 50% government capex incentive and targeted commercial production from April 2027, gives Syrma SGS Technology a path to capture upstream value that can lift consolidated EBITDA and ROCE once utilization and asset turns build."
Consider what happens if a single pressure point in Syrma SGS Technology’s business quietly changes the balance between rapid growth and earnings quality.
If that pressure point interests you, the full narrative for Syrma SGS Technology shows where growth could be accelerating and how earnings quality may be decoupling from simple volume swings.
Fresh breakouts often appear quietly. Then momentum builds and prices move before most even notice. Use targeted stock lists while the data still matters and get in early.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com